scispace - formally typeset
J

John L. Cameron

Researcher at Johns Hopkins University School of Medicine

Publications -  134
Citations -  14704

John L. Cameron is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Pancreatectomy & Pancreaticoduodenectomy. The author has an hindex of 47, co-authored 134 publications receiving 13087 citations. Previous affiliations of John L. Cameron include Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.

TL;DR: This single institution, high-volume experience indicates that pancreaticoduodenectomy can be performed safely for a variety of malignant and benign disorders of the pancreas and periampullary region.
Journal ArticleDOI

Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators

TL;DR: Factors influencing long-term survival after resection in patients with adenocarcinoma of the head, neck, uncinate process, body, or tail of the pancreas are examined to decrease the independent significance of tumor location and nodal status.
Journal ArticleDOI

1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.

TL;DR: Patients who have cancers with favorable pathological features have a statistically significant improved long-term survival, and pathological factors having a significant impact on survival included tumor diameter, resection margin status, lymph node status, and histologic grade.
Journal ArticleDOI

Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients

TL;DR: Multivariate analyses indicated the strongest predictors of long-term survival were diploid tumor DNA content, tumor diameter < 3 cm, negative nodal status, negative resection margins, and decade of resection.
Journal ArticleDOI

Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial.

TL;DR: It is suggested that intraoperative chemical splanchnicectomy with alcohol significantly reduces or prevents pain in patients with unresectable pancreatic cancer.